Meijer Berry Antacid Hbg

Description

Meijer Berry Antacid is presented in a dosage form of chewable tablets, available in a package containing 28 count. The product is formulated to provide relief from heartburn and indigestion. The tablets are characterized by a berry flavor, enhancing palatability for users.

Uses and Indications

This drug is indicated for the relief of heartburn, sour stomach, and acid indigestion. It is also effective in alleviating upset stomach associated with these symptoms. Additionally, this drug provides relief from bloating, pressure, or a stuffed feeling commonly referred to as gas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older may chew and swallow 1 to 2 chewable tablets every 2 to 4 hours as needed for symptom relief. It is important not to exceed a total of 5 chewable tablets within a 24-hour period.

For children under 12 years of age, consultation with a healthcare professional is recommended prior to administration.

Contraindications

The product should not be used at the maximum dosage for more than 2 weeks unless advised and supervised by a physician. This limitation is in place to ensure patient safety and to mitigate potential risks associated with prolonged high-dose use. No other contraindications have been specified in the provided data.

Warnings and Precautions

The use of this product is contraindicated in individuals with a history of allergic reactions to the product or any of its components. Healthcare professionals should ensure that patients are screened for such allergies prior to administration.

It is advised that the maximum dosage not be utilized for a duration exceeding two weeks unless specifically directed and monitored by a physician. This precaution is essential to mitigate the risk of potential adverse effects associated with prolonged high-dose usage.

Currently, there are no specific laboratory tests recommended for monitoring during the use of this product. However, healthcare providers should remain vigilant and assess the patient's overall health status regularly.

In the absence of detailed instructions regarding emergency medical assistance or specific circumstances under which patients should discontinue use and consult their healthcare provider, practitioners are encouraged to maintain open communication with patients about any unexpected reactions or concerns that may arise during treatment.

Side Effects

Patients should be aware that the use of this product is contraindicated in individuals who have a history of allergic reactions to the product or any of its ingredients.

In addition to the contraindications, it is important to note that antacids may interact with certain prescription medications. Patients should consult their healthcare provider to discuss potential interactions and ensure safe use of this product alongside their current medications.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to monitor the timing of antacid administration in relation to other medications to minimize these interactions. Specifically, antacids should be taken at least 2 hours apart from other drugs to ensure optimal therapeutic outcomes.

Packaging & NDC

Below are the non-prescription pack sizes of Meijer Berry Antacid Hbg (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may chew and swallow 1 to 2 chewable tablets every 2 to 4 hours as needed, with a maximum of 5 chewable tablets in a 24-hour period. For children under 12 years of age, it is advised to consult a doctor before use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario. Continuous assessment and supportive care are critical in managing the patient effectively until the effects of the overdose have resolved.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities to enhance the understanding of the substance's safety profile and to contribute to the body of knowledge regarding its management.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

Postmarketing experience has been gathered through voluntary reports and surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events or concerns related to the use of the product. For inquiries or to report an adverse event, individuals may contact 1-800-245-2898.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion.

Patients should be informed not to exceed the maximum dosage for more than two weeks unless directed and supervised by a physician. It is important for patients to understand that prolonged use at maximum dosage may lead to adverse effects.

While using this product, patients may experience constipation. Healthcare providers should discuss this potential side effect and recommend appropriate measures to manage it if it occurs.

Additionally, patients should be encouraged to consult with their doctor or pharmacist before using this product if they are currently taking any prescription medications. This is particularly important as antacids may interact with certain prescription drugs, and healthcare providers should ensure that patients are aware of this risk.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored in a dry place at a temperature range of 20° to 25°C (68° to 77°F). Proper storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Meijer Berry Antacid Hbg, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)